Prevalence and Risk Factors of Potential Drug-Drug Interactions in the In-Patient Medical Wards: A Hospital-Based Cross-Sectional Study
Pharmaceutical Science-Pharmacy practice
DOI:
https://doi.org/10.22376/ijpbs/lpr.2022.12.6.P250-256Keywords:
Drug interaction, DDI, Predictors, Prevalence and SeverityAbstract
Evidence shows that half of the Adverse Drug Reactions (ADRs) resulting from Drug-Drug Interactions (DDI) are predictable and preventable. Hospitalized patients are more expected to develop DDI. The current study aims to assess the prevalence, risk factors, and severity of PDDIs among hospitalized patients. This is a cross-sectional study that was conducted in medical wards of a NGO charity hospital located in Bathalapalli, Anantapur district. Patients aged 18 years or more, and admitted to the in-patient medical wards taking more than one medication have been selected for the study. A total of 310 subjects who met the study criteria were enrolled in the study after taking oral and written informed consent. Patient demographics, a list of medications, and clinical characteristics were collected from admission to discharge by the review of medical records and patient interviews. The collected data were subjected to identify and grade the severity of PDDI by using IBM Micromedex® Drug Interaction Checker. Among 310 in-patients, 82 cases had 127 PDDI with a prevalence of 26.45%. The majority of the PDDI are moderate (57; 44.9%) in severity level. Factors like the advanced age group of more than 40 years, more than one comorbidity, staying in the hospital for more than four days, and more than five drugs per prescription were positively associated with having PDDI with a P value less than 0.05. Clinical pharmacists need to work with the healthcare team to provide interventions to reduce clinically significant interactions and improve clinical outcomes.
References
Murtaza G, Khan MYG, Azhar S, Khan SA, Khan TM. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J. 2016 Mar;24(2):220-5. doi: 10.1016/j.jsps.2015.03.009, PMID 27013915.
Rashid K, Khan Y, Ansar F, Waheed A, Aizaz M. Potential drug-drug interactions in hospitalized medical patients: data from low resource settings. Cureus. 2021 Aug 20;13(8):e17336. doi: 10.7759/cureus.17336, PMID 34557372.
Shah H, Shah NJ. Drug interactions. In: Singapore: Springer Singapore. p. 197-204; 2019. Introduction to basics of pharmacology and toxicology [internet] Raj GM, Raveendran R, editors [cited Aug 28 2022]. Available from: http://link.springer.com/10.1007/978-981-32-9779-1_12.
Tesfaye ZT, Nedi T. Potential drug–drug interactions in inpatients treated at the Internal Medicine ward of Tikur Anbessa Specialized Hospital. DHPS. 2017 Aug;Volume(9):71-6. doi: 10.2147/DHPS.S126336.
Kaliamurthy K, Kumar A, Punniyakotti S, Devanandan P. Study of drug-drug interactions in general medicine department of a tertiary Care Hospital. J App Pharm Sci. 2015:122-4. doi: 10.7324/JAPS.2015.501221.
Rodrigues MCS, Oliveira de Cd. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Latino-Am Enfermagem [Internet]. 2016;24(0):e2800. doi: 10.1590/1518-8345.1316.2800, PMID 27598380.
Helms RA, editor. Textbook of therapeutics: drug and disease management. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. 2780 p.
Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991 Feb 7;324(6):377-84. doi: 10.1056/NEJM199102073240605, PMID 1824793.
To err is human: building a safer health system [internet]. Washington, DC: National Academies Press; 2000 [cited Jul 16 2022]. Available from: http://www.nap.edu/catalog/9728.
Bethi Y, Shewade DG, Dutta TK, Gitanjali B. Prevalence and predictors of potential drug-drug interactions in patients of internal medicine wards of a tertiary care hospital in India. Eur J Hosp Pharm. 2018 Nov;25(6):317-21. doi: 10.1136/ejhpharm-2017-001272, PMID 31157049.
Ahmad A, Khan MU, Haque I, Ivan R, Dasari R, Revanker M et al. Evaluation of potential drug-drug interactions in general medicine ward of teaching hospital in Southern India. J Clin Diagn Res. 2015;9(2):FC10-3. doi: 10.7860/JCDR/2015/11264.5608, PMID 25859467.
Mathur A, Jain N, Sharma A, Shah PC. Potential drug-drug interactions among elderly in-patients with cardiac illness at a tertiary care centre. Int J Basic Clin Pharmacol. 2020 Feb 25;9(3):470. doi: 10.18203/2319-2003.ijbcp20200724.
Ayenew W, Asmamaw G, Issa A. Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studies. BMC Pharmacol Toxicol. 2020 Dec;21(1):63. doi: 10.1186/s40360-020-00441-2, PMID 32831135.
Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BHc. Hospitalisations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidem. Drug Saf. 2007 Jun;16(6):641-51.
Giardina C, Cutroneo PM, Mocciaro E, Russo GT, Mandraffino G, Basile G, et al. Adverse drug reactions in hospitalized patients: results of the FORWARD (facilitation of reporting in hospital ward) study. Front Pharmacol. 2018;9:350. doi: 10.3389/fphar.2018.00350, PMID 29695966.
Bhagavathula AS, Berhanie A, Tigistu H, Abraham Y, Getachew Y, Khan TM, et al. prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia. Asian Pac J Trop Biomed. 2014 May;4(Suppl 1);Suppl 1:S204-8. doi: 10.12980/APJTB.4.2014C1172, PMID 25183081.
Ismail M, Iqbal Z, Khattak M, Javaid A, Khan M, Khan T, et al. Potential drug-drug interactions in psychiatric ward of a tertiary Care Hospital: prevalence, levels and association with risk factors. Trop J Pharm Res. 2012 Apr 24;11(2):289-96. doi: 10.4314/tjpr.v11i2.17.
Das S, Behera SK, Xavier AS, Dharanipragada S, Selvarajan S. Are drug-drug interactions a real clinical concern? Perspect Clin Res. 2019;10(2):62-6. doi: 10.4103/picr.PICR_55_18, PMID 31008071.
Aleksić DZ, Milosavljević MN, Stefanović SM, Bukonjić A, Milosavljević JZ, Janković SM, et al. Risk factors for potential drug-drug interactions in patients with myasthenia gravis. Neurol Res. 2021 Dec 2;43(12):1023-30. doi: 10.1080/01616412.2021.1948767, PMID 34233604.
IBM. Micromedex® Drug Interaction Checking (Electronic Version) [internet]. Greenwood Village, CO: IBM Watson Health. Available from: https://www.micromedexsolutions.com/.
Od J, RH SR, R, SR. Study of drug-drug interactions in the medication charts in medicine wards at a tertiary Care Hospital, Bangalore. Indian J Pharm Pract. 2012;5(4):61-4.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Y Samhitha Reddy, K Somasekhar Reddy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.